Global expansion Uptake Strategies Ltd recently joined Prescient Healthcare Group, creating combined opportunities across a larger global footprint. Leverage the expanded international reach and access to Prescient’s eight locations to propose integrated, cross-border healthcare consulting solutions that pair Uptake’s commercial strategy capabilities with Prescient’s insights and real-world evidence strengths.

Awarded credibility The King’s Award for Enterprise in International Trade and multiple industry recognitions (PMEA wins, GPTW Best Workplaces for Women) provide strong credibility and trust signals. Use these accolades in outreach to healthcare clients seeking proven, high-impact consultancy partners with a track record of international success and patient-centric approaches.

Healthcare focus Specialization in planning, strategy, capability building, launch, early commercialisation and transformation for pharma and biotech indicates a clear alignment with launches, market access and commercial optimisation needs. Target biotech startups through scale-up phases and established pharma companies pursuing faster time-to-market and evidence-driven strategies.

Customer impact Recent news highlights include PMEA award wins and recognition as finalists, underscoring differentiated outcomes and practical impact. Position Uptake as a partner for measurable improvements in medical and commercial performance, with case-motivated discussions around patient-centricity and value demonstration.

Growth potential Revenue range indicates mid-market footprint with room to scale, and the acquisition by Prescient HG offers cross-sell opportunities into Insights, Medical affairs, and real-world evidence services. Propose bundled offerings and joint go-to-market motions that combine Uptake’s strategy capabilities with Prescient’s data and scientific depth.